AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model

Single domain antibodies (VHHs) are potentially disruptive therapeutics, with important biological value for treatment of several diseases, including neurological disorders. However, VHHs have not been widely used in the central nervous system (CNS), largely because of their restricted blood–brain barrier (BBB) penetration. Here, we propose a gene transfer strategy based on BBB-crossing adeno-associated virus (AAV)-based vectors to deliver VHH directly into the CNS. As a proof-of-concept, we explored the potential of AAV-delivered VHH to inhibit BACE1, a well-characterized target in Alzheimer’s disease. First, we generated a panel of VHHs targeting BACE1, one of which, VHH-B9, shows high selectivity for BACE1 and efficacy in lowering BACE1 activity in vitro. We further demonstrate that a single systemic dose of AAV-VHH-B9 produces positive long-term (12 months plus) effects on amyloid load, neuroinflammation, synaptic function, and cognitive performance, in the AppNL-G-F Alzheimer’s mouse model. These results constitute a novel therapeutic approach for neurodegenerative diseases, which is applicable to a range of CNS disease targets

Eddy Study to Understand Physical-Chemical-Biological Coupling and the Biological Carbon Pump as a Function of Eddy Type off West Africa, Cruise No. M160, 23.11.2019 - 20.12.2019, Mindelo (Cabo Verde) - Mindelo (Cabo Verde)

Cruise M160 is part of concerted MOSES/REEBUS Eddy Study featuring three major research expeditions (M156, M160, MSM104). It aims to develop both a qualitative and quantitative understanding of the role of physical-chemical-biological coupling in eddies for the biological pump. The study is part of the MOSES “Ocean Eddies” event chain, which follows three major hypotheses to be addressed by the MOSES/REEBUS field campaigns: (1) Mesoscale and sub-mesoscale eddies play an important role in transferring energy along the energy cascade from the large-scale circulation to dissipation at the molecular level. (2) Mesoscale and sub-mesoscale eddies are important drivers in determining onset, magnitude and characteristics of biological productivity in the ocean and contribute significantly to global primary production and particle export and transfer to the deep ocean. (3) Mesoscale and sub-mesoscale eddies are important for shaping extreme biogeochemical environments (e.g., pH, oxygen) in the oceans, thus acting as a source/sink function for greenhouse gases. In contrast to the other two legs, MOSES Eddy Study II during M160 did not include any benthic work but focused entirely on the pelagic dynamics within eddies. It accomplished a multi-disciplinary, multi-parameter and multi-platform study of two discrete cyclonic eddies in an unprecedented complexity. The pre-cruise search for discrete eddies suitable for detailed study during M160 had already started a few months prior to the cruise. Remote sensing data products (sea surface height, sea surface temperature, ocean color/chlorophyll a) were used in combination with eddy detection algorithms and numerical modelling to identify and track eddies in the entire eddy field off West Africa. In addition, 2 gliders and 1 waveglider had been set out from Mindelo/Cabo Verde for pre-cruise mapping of the potential working area north of the Cabo Verdean archipelago. At the start of M160, a few suitable eddies – mostly of cyclonic type – had been identified, some of which were outside the safe operation range of the motorglider plane. As technical problems delayed the flight operations, the first eddy (center at 14.5°N/25°W) for detailed study was chosen to the southwest of the island of Fogo. It was decided to carry out a first hydrographic survey there followed by the deployment of a suite of instruments (gliders, waveglider, floats, drifter short-term mooring). Such instrumented, we left this first eddy and transited – via a strong anticyclonic feature southwest of the island of Santiago – to the region northeast of the island of Sal, i.e. in the working range of the glider plane. During the transit, a full suite of underway measurements as well as CTD/RO section along 22°W (16°-18.5°N) were carried in search for sub-surface expressions of anticyclonic eddy features. In the northeast, we had identified the second strong cyclonic eddy (center at 18°N/22.5°W) which was chosen for detailed study starting with a complete hydrographic survey (ADCP, CTD/RO, other routine station work). After completion of the mesoscale work program, we identified a strong frontal region at the southwestern rim of the cyclonic eddy, which was chosen for the first sub-mesoscale study with aerial observation component. There, the first dye release experiment was carried out which consisted of the dye release itself followed by an intense multi-platforms study of the vertical and horizontal spreading of the initial dye streak. This work was METEOR-Berichte, Cruise M160, Mindelo – Mindelo, 23.11.2019 4 – 20.12.2019 supported and partly guided by aerial observation of the research motorglider Stemme, which was still somewhat compromised by technical issues and meteorological conditions (high cloud cover, Saharan dust event). Nevertheless, this first dye release experiment was successful and showed rapid movement of the dynamic meandering front. After completion of work on this second eddy and execution of a focused sampling program at the Cape Verde Ocean Observation, RV METEOR returned to the first eddy for continuation of the work started there in the beginning of the cruise. This was accompanied by a relocation of the airbase of Stemme from the international airport of Sal to the domestic airport of Fogo. The further execution of the eddy study at this first eddy, which again included a complete hydrographic survey followed by a mesoscale eddy study with dye release, was therefore possible with aerial observations providing important guidance for work on RV METEOR. Overall, M160 accomplished an extremely intense and complex work program with 212 instrument deployments during station work, 137 h of observation with towed instruments and a wide range of underway measurements throughout the cruise. Up to about 30 individually tracked platforms (Seadrones, glider, wavegliders, drifters, floats) were in the water at the same time providing unprecedented and orchestrated observation capabilities in an eddy. All planned work components were achieved and all working groups acquired the expected numbers of instrument deployments and sampling opportunities

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

We identified rare coding variants associated with Alzheimer’s disease (AD) in a 3-stage case-control study of 85,133 subjects. In stage 1, 34,174 samples were genotyped using a whole-exome microarray. In stage 2, we tested associated variants (P<1×10-4) in 35,962 independent samples using de novo genotyping and imputed genotypes. In stage 3, an additional 14,997 samples were used to test the most significant stage 2 associations (P<5×10-8) using imputed genotypes. We observed 3 novel genome-wide significant (GWS) AD associated non-synonymous variants; a protective variant in PLCG2 (rs72824905/p.P522R, P=5.38×10-10, OR=0.68, MAFcases=0.0059, MAFcontrols=0.0093), a risk variant in ABI3 (rs616338/p.S209F, P=4.56×10-10, OR=1.43, MAFcases=0.011, MAFcontrols=0.008), and a novel GWS variant in TREM2 (rs143332484/p.R62H, P=1.55×10-14, OR=1.67, MAFcases=0.0143, MAFcontrols=0.0089), a known AD susceptibility gene. These protein-coding changes are in genes highly expressed in microglia and highlight an immune-related protein-protein interaction network enriched for previously identified AD risk genes. These genetic findings provide additional evidence that the microglia-mediated innate immune response contributes directly to AD development

AAV mediated delivery of a novel anti-BACE1 VHH reduces Abeta in an Alzheimer’s disease mouse model

ABSTRACT Single domain antibodies (VHH) are potentially disruptive therapeutics, with important biological value for treatment of several diseases, including neurological disorders. However, VHH have not been widely used in the central nervous system (CNS), as it is hard to reach therapeutic levels, both because of their restricted blood-brain-barrier penetration and their apparent rapid clearance from the parenchyma. Here, we propose a gene transfer strategy based on adeno-associated virus (AAV)-based vectors to deliver VHH directly into the CNS, ensuring continuous production at therapeutic levels. As a proof-of-concept, we explored the potential of AAV-delivered VHH to inhibit BACE1, a well-characterized target in Alzheimer’s disease. First, we generated a panel of VHHs targeting BACE1. One of them, VHH-B9, showed high selectivity for BACE1 and efficacy in lowering BACE1 activity in vitro. We then went on to demonstrate significant reductions in amyloid beta (Aβ) levels after AAV-based delivery of VHH-B9 into the CNS of a mouse model of cerebral amyloidosis. These results constitute a novel therapeutic approach for neurodegenerative diseases, which is applicable to a range of CNS disease targets.status: publishe

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

Purpose We assessed the uptake of fertility preservation (FP), recovery of ovarian function (OFR) after chemotherapy, live birth after breast cancer, and breast cancer outcomes in women with early-stage breast cancer. Methods Women aged below 41 years and referred to our center for FP counseling between 2008 and 2015 were included. Data on patient and tumor characteristics, ovarian function, cryopreservation (embryo/oocyte) and transfer, live birth, and disease-free survival were collected. Kaplan-Meier analyses were performed for time-to-event analyses including competing risk analyses, and patients with versus without FP were compared using the logrank test. Results Of 118 counseled women with a median age of 31 years (range 19-40), 34 (29%) chose FP. Women who chose FP had less often children, more often a male partner and more often favorable tumor characteristics. The 5-year OFR rate was 92% for the total group of counseled patients. In total, 26 women gave birth. The 5-year live birth rate was 27% for the total group of counseled patients. Only three women applied for transfer of their cryopreserved embryo(s), in two combined with preimplantation genetic diagnosis (PGD) because of BRCA1-mutation carrier ship. The 5-year disease-free survival rate was 91% versus 88%, for patients with versus without FP (P = 0.42). Conclusions Remarkably, most women achieved OFR, probably related to the young age at diagnosis. Most pregnancies occurred spontaneously, two of three women applied for embryo transfer because of the opportunity to apply for PGD

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

Purpose We assessed the uptake of fertility preservation (FP), recovery of ovarian function (OFR) after chemotherapy, live birth after breast cancer, and breast cancer outcomes in women with early-stage breast cancer. Methods Women aged below 41 years and referred to our center for FP counseling between 2008 and 2015 were included. Data on patient and tumor characteristics, ovarian function, cryopreservation (embryo/oocyte) and transfer, live birth, and disease-free survival were collected. Kaplan-Meier analyses were performed for time-to-event analyses including competing risk analyses, and patients with versus without FP were compared using the logrank test. Results Of 118 counseled women with a median age of 31 years (range 19-40), 34 (29%) chose FP. Women who chose FP had less often children, more often a male partner and more often favorable tumor characteristics. The 5-year OFR rate was 92% for the total group of counseled patients. In total, 26 women gave birth. The 5-year live birth rate was 27% for the total group of counseled patients. Only three women applied for transfer of their cryopreserved embryo(s), in two combined with preimplantation genetic diagnosis (PGD) because of BRCA1-mutation carrier ship. The 5-year disease-free survival rate was 91% versus 88%, for patients with versus without FP (P = 0.42). Conclusions Remarkably, most women achieved OFR, probably related to the young age at diagnosis. Most pregnancies occurred spontaneously, two of three women applied for embryo transfer because of the opportunity to apply for PGD